Medical News

RSS

Medical Connections second quarter revenue decreases 6.8% to $1,779,938

Medical Connections Holdings, Inc. a national provider of healthcare staffing services, announced today its operating results for the second quarter and the first six months of 2011. Revenue for the second quarter of 2011 was $1,779,938, a decrease of 6.8% when compared to the second quarter of 2010.

18 Aug 2011

NPS submits NDA CMC section to FDA for GATTEX

NPS Pharmaceuticals, Inc., a specialty pharmaceutical company developing orphan therapeutics for rare gastrointestinal and endocrine disorders, today announced that it has submitted the chemistry, manufacturing and controls (CMC) section of its new drug application (NDA) for GATTEX® (teduglutide) to the U.S. Food and Drug Administration (FDA).

18 Aug 2011

Scientists artificially grow brain cells from Parkinson's patients to find treatment

The UK's population is ageing and with it comes an increased risk of developing age-related diseases such as Parkinson's. About 70% of dopamine producing brain cells will have been lost by the time a sufferer visits the doctor, with symptoms that include difficulties with movement and a resting tremor. A progressive neurodegenerative disease, Parkinson's affects about 120,000 people in the UK.

18 Aug 2011

AHRQ awards Johns Hopkins Evidence-based Practice Center $475,000 for study on effective wound care

An estimated $25 billion is spent annually on treating chronic wounds on patients in the United States. These chronic wounds deeply affect the quality of life of more than six million people who have them. The most common types of chronic skin wounds and skin ulcers are related to venous disease (conditions related to or caused by veins that become diseased or abnormal).

18 Aug 2011

First Edition: August 18, 2011

"The SSI program for children is rapidly expanding, with the biggest increase among kids with mental, behavioral and learning disorders, including ADHD, speech delays, autism, and bipolar disorder. But as it pulls in children like Hulston, the program is sparking criticism in Congress.

18 Aug 2011

PrEP raises questions regarding 'risk disinhibition' and drug resistance

Nature News reports on "the possibility of unintended public-health consequences" of pre-exposure prophylaxis (PrEP) for HIV and pharmaceutical company Gilead's plan to ask the FDA to evaluate its combination antiretroviral (ARV) drug Truvada for use in healthy people.

18 Aug 2011

Cortex second quarter net loss decreases to $356,000

Cortex Pharmaceuticals, Inc. reported a net loss of approximately $356,000, or $0.00 per share, for the quarter ended June 30, 2011, compared with a net loss of approximately $2,454,000, or $0.04 per share, for the corresponding prior year period, with the difference reflecting revenues in the current year period from the Company's option agreement with Servier, France's largest privately held pharmaceutical company.

18 Aug 2011

ProtoKinetix completes sale of AAGP tool for protecting delicate cells in research

ProtoKinetix, announces today that it has completed the sale of (AAGP) as a vital tool to protect delicate cells in the process of utilizing stem cells, to treat disease and injury. This development will enable the Company to ramp up sales of the unique AAGP family of molecules to the medical research community.

18 Aug 2011

Lucentis receives Health Canada approval for treatment of retinal vein occlusion

Following a priority review, Health Canada has approved Lucentis (ranibizumab) as a treatment for vision loss resulting from retinal vein occlusion (RVO). This makes Lucentis the first approved treatment of its class in Canada for this debilitating condition. Patients will now have access to a treatment that is proven to be effective and has an established safety profile.

18 Aug 2011

Tobacco companies sue federal government over graphic warnings

Tobacco companies want a judge to put a stop to new graphic cigarette labels that include the sewn-up corpse of a smoker and pictures of diseased lungs, saying they unfairly urge adults to shun their legal products and will cost millions to produce.

18 Aug 2011

Blocking pathway for generating energy can kill cancer cells

Cancer Research UK scientists have found that blocking the pathway used by some kidney cancer cells to generate energy can kill the cancer cells, sparing the healthy ones.

18 Aug 2011

How the Medco-Express Scripts merger could impact consumer pocketbooks

You probably haven't heard of either Express Scripts or Medco Health Services, but their plans to merge in a $29 billion deal, announced last month, may have an impact on your pocketbook.

18 Aug 2011

Pressure-reduction mattresses could help hospitals reduce health care costs

Hospitals could reduce health care costs arising from pressure ulcers, commonly known as bedsores, by investing in pressure-reduction mattresses for elderly patients in emergency departments, according to new research from the University of Toronto.

18 Aug 2011

CCP expands hybrid model services to large medical groups and health systems

Concierge Choice Physicians (CCP), the nation's pioneer in the hybrid model of concierge medicine programs, announced today the expansion of its services to mid-size and large medical groups, and to national and regional health systems.

18 Aug 2011

EMA accepts Merck and ARIAD's MAA for ridaforolimus to treat metastatic bone sarcomas

Merck, known outside the United States and Canada as MSD, and ARIAD Pharmaceuticals, Inc., today announced that the European Medicines Agency (EMA) has completed its administrative validation process for the regulatory application for ridaforolimus, an investigational oral mTOR inhibitor developed for the treatment of metastatic soft-tissue or bone sarcomas in patients who had a favorable response to chemotherapy.

18 Aug 2011

MSF warns global shortage of drug-resistant TB treatment likely

As countries increase the use of the GeneXpert test, a two-hour molecular TB test released in 2010, "enabl[ing] them to diagnose more patients with drug-resistant tuberculosis (DR-TB), a worldwide shortage of the drugs to treat these patients is likely, Medecins Sans Frontieres (MSF) warns," according to PlusNews.

18 Aug 2011

National analysis identifies Columbus as one of the Hypertension Hot Spots in the U.S.

A national analysis conducted by Sperling's BestPlaces and sponsored by Takeda Pharmaceuticals North America, Inc., identified Columbus, Ohio, as one of the nation's Hypertension Hot Spots, or cities that have hypertension risk factors and complications.

18 Aug 2011

Henry Schein authorizes repurchase of $200M shares of common stock

Henry Schein, Inc., the largest provider of health care products and services to office-based practitioners, today announced that its Board of Directors has authorized the repurchase of up to $200 million of shares of the Company's common stock.

18 Aug 2011

BTI completes SUGARDOWN human clinical study on blood sugar management

Boston Therapeutics, Inc. (BTI), a public company registered with the SEC and a developer of diabetes therapeutics, announced today the completion of a trial in healthy volunteers performed at the University of Sydney on SUGARDOWN, a dietary supplement designed to reduce post-meal elevation of blood glucose.

18 Aug 2011

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash Corporation, a medical device company primarily focused on regenerative medicine for a wide range of medical procedures, today reported the results for its fourth quarter and fiscal year ended June 30, 2011.

18 Aug 2011